Top Markets
Coin of the day
Oxurion N.V. Oxurion N.V.

Oxurion N.V.

OXUR
Ранг среди акций #39565
Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a... Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a biopharmaceutical firm focused on researching, developing, and bringing to market treatments for various ocular conditions worldwide. Its primary commercialized offering is JETREA, a medication used to address vitreomacular adhesion and vitreomacular traction. The company's development pipeline includes THR-149, a plasma kallikrein inhibitor currently undergoing Phase II clinical trials for diabetic macular edema (DME), and THR-687, an integrin antagonist also in Phase II trials for DME. Oxurion has forged strategic partnerships with Bicycle Therapeutics, INC Research, and Galapagos NV. The organization was formerly known as ThromboGenics NV before officially changing its name to Oxurion NV in September 2018.
Цена акции
$0.003084
Рыночная капитализация
$434.03K
Изменение (1 день)
-7.14%
Изменение (1 год)
-89.24%
Страна
BE
Торговля Oxurion N.V. (OXUR)

Категория

История цены акций Oxurion N.V. (OXUR)
Наивысшая цена закрытия: $0.00 2026-08-01

Наименьшая цена закрытия: $62.97K 2006-07-01
История цены акций Oxurion N.V. с 2006 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) 5.23%
2025 -96.55%
2024 -97.10%
2023 -94.05%
2022 -99.22%
2021 -35.88%
2020 10.67%
2019 -29.09%
2018 -4.13%
2017 62.47%
2016 -25.93%
2015 -55.06%
2014 -66.50%
2013 -54.24%
2012 123.36%
2011 -17.09%
2010 25.57%
2009 132.05%
2008 -27.90%
2007 10.78%
2006 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$517.18 32.51%
US
$857.76 31.47%
NL
$737.68 8.00%
CH
$1.07K -6.40%
KR
$258.82 14.34%
BE